Drug-induced kidney injury in Chinese critically ill pediatric patients

Background: Drug-induced acute kidney injury (DIKI) is a common adverse drug reaction event but is less known in pediatric patients. The study explored the DIKI in Chinese pediatric patients using the Pediatric Intensive Care database (PIC).Method: We screened pediatric patients with acute kidney in...

Full description

Bibliographic Details
Main Authors: Biwen Hu, Ling Ye, Tong Li, Zeying Feng, Longjian Huang, Chengjun Guo, Li He, Wei Tan, Guoping Yang, Zhiling Li, Chengxian Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.993923/full
_version_ 1811204735563202560
author Biwen Hu
Ling Ye
Tong Li
Zeying Feng
Longjian Huang
Chengjun Guo
Li He
Wei Tan
Guoping Yang
Zhiling Li
Chengxian Guo
author_facet Biwen Hu
Ling Ye
Tong Li
Zeying Feng
Longjian Huang
Chengjun Guo
Li He
Wei Tan
Guoping Yang
Zhiling Li
Chengxian Guo
author_sort Biwen Hu
collection DOAJ
description Background: Drug-induced acute kidney injury (DIKI) is a common adverse drug reaction event but is less known in pediatric patients. The study explored the DIKI in Chinese pediatric patients using the Pediatric Intensive Care database (PIC).Method: We screened pediatric patients with acute kidney injury (AKI) using the KDIGO criteria from the PIC and then assessed the relationship between their drugs and DIKI using the Naranjo scale. For the fifteen frequently used DIKI-suspected drugs, we divided patients into drug-exposed and non-exposed groups, using the outcome of whether DIKI was presented or not. Propensity score matching (PSM) was used to control for the effects of four confounders, age, gender, length of hospital stay, and major diagnosis. Unconditional logistic regression was used to identify statistically significant differences between the two groups.Results: A total of 238 drugs were used 1,863 times by the 81 patients with DIKI during their hospital stay. After screening the Naranjo scale to identify the top 15 suspected DIKI drugs with a high frequency of use, we found that furosemide injection (p = 0.001), midazolam injection (p = 0.001), 20% albumin prepared from human plasma injection (p = 0.004), fentanyl citrate injection (p = 0.001), compound glycyrrhizin injection (p = 0.026), vancomycin hydrochloride for intravenous (p = 0.010), and milrinone lactate injection (p = 0.009) were associated with DIKI.Conclusion: In critically ill pediatric patients, DIKI is more likely to occur after using furosemide injection, midazolam injection, 20% albumin prepared from human plasma injection, fentanyl citrate injection, compound glycyrrhizin injection, vancomycin hydrochloride for intravenous, milrinone lactate injection.
first_indexed 2024-04-12T03:17:42Z
format Article
id doaj.art-7a96489210c6485a816115af30f5c0bc
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-12T03:17:42Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-7a96489210c6485a816115af30f5c0bc2022-12-22T03:50:00ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-09-011310.3389/fphar.2022.993923993923Drug-induced kidney injury in Chinese critically ill pediatric patientsBiwen Hu0Ling Ye1Tong Li2Zeying Feng3Longjian Huang4Chengjun Guo5Li He6Wei Tan7Guoping Yang8Zhiling Li9Chengxian Guo10Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaWest Guangxi Key Laboratory for Prevention and Treatment of High-Incidence Diseases, Youjiang Medical University for Nationalities, Baise, ChinaSchool of Applied Mathematics, Guangdong University of Technology, Guangzhou, ChinaDepartment of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Neonatology, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Region, ChinaCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaBackground: Drug-induced acute kidney injury (DIKI) is a common adverse drug reaction event but is less known in pediatric patients. The study explored the DIKI in Chinese pediatric patients using the Pediatric Intensive Care database (PIC).Method: We screened pediatric patients with acute kidney injury (AKI) using the KDIGO criteria from the PIC and then assessed the relationship between their drugs and DIKI using the Naranjo scale. For the fifteen frequently used DIKI-suspected drugs, we divided patients into drug-exposed and non-exposed groups, using the outcome of whether DIKI was presented or not. Propensity score matching (PSM) was used to control for the effects of four confounders, age, gender, length of hospital stay, and major diagnosis. Unconditional logistic regression was used to identify statistically significant differences between the two groups.Results: A total of 238 drugs were used 1,863 times by the 81 patients with DIKI during their hospital stay. After screening the Naranjo scale to identify the top 15 suspected DIKI drugs with a high frequency of use, we found that furosemide injection (p = 0.001), midazolam injection (p = 0.001), 20% albumin prepared from human plasma injection (p = 0.004), fentanyl citrate injection (p = 0.001), compound glycyrrhizin injection (p = 0.026), vancomycin hydrochloride for intravenous (p = 0.010), and milrinone lactate injection (p = 0.009) were associated with DIKI.Conclusion: In critically ill pediatric patients, DIKI is more likely to occur after using furosemide injection, midazolam injection, 20% albumin prepared from human plasma injection, fentanyl citrate injection, compound glycyrrhizin injection, vancomycin hydrochloride for intravenous, milrinone lactate injection.https://www.frontiersin.org/articles/10.3389/fphar.2022.993923/fulldrug-induced kidney injuryacute kidney injuryrational drug userational medicationpediatrics
spellingShingle Biwen Hu
Ling Ye
Tong Li
Zeying Feng
Longjian Huang
Chengjun Guo
Li He
Wei Tan
Guoping Yang
Zhiling Li
Chengxian Guo
Drug-induced kidney injury in Chinese critically ill pediatric patients
Frontiers in Pharmacology
drug-induced kidney injury
acute kidney injury
rational drug use
rational medication
pediatrics
title Drug-induced kidney injury in Chinese critically ill pediatric patients
title_full Drug-induced kidney injury in Chinese critically ill pediatric patients
title_fullStr Drug-induced kidney injury in Chinese critically ill pediatric patients
title_full_unstemmed Drug-induced kidney injury in Chinese critically ill pediatric patients
title_short Drug-induced kidney injury in Chinese critically ill pediatric patients
title_sort drug induced kidney injury in chinese critically ill pediatric patients
topic drug-induced kidney injury
acute kidney injury
rational drug use
rational medication
pediatrics
url https://www.frontiersin.org/articles/10.3389/fphar.2022.993923/full
work_keys_str_mv AT biwenhu druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT lingye druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT tongli druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT zeyingfeng druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT longjianhuang druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT chengjunguo druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT lihe druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT weitan druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT guopingyang druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT zhilingli druginducedkidneyinjuryinchinesecriticallyillpediatricpatients
AT chengxianguo druginducedkidneyinjuryinchinesecriticallyillpediatricpatients